Xeris Pharmaceuticals Inc (XERS) — Capital Reinvestment Ratio
Xeris Pharmaceuticals Inc (XERS) has a Capital Reinvestment Ratio of 0.03x as of June 2026, meaning it reinvests 0% of its operating cash flow ($8.26 Million) in capital expenditures ($209.00K). Check XERS tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xeris Pharmaceuticals Inc Capital Reinvestment Ratio (2025–2025)
This chart tracks Xeris Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Xeris Pharmaceuticals Inc (XERS) cash flow conversion.
Annual Capital Reinvestment Ratio for Xeris Pharmaceuticals Inc (2025–2025)
Year-by-year Capital Reinvestment Ratio for Xeris Pharmaceuticals Inc from 2025 to 2025. See free cash flow generation of Xeris Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | $28.63 Million | $696.00K | — |